Use of the Community-Derived Open-Source Automated Insulin Delivery Loop System in Type 2 Diabetes
Authors' conclusion
These data, though limited, suggest that the Loop system is likely to be effective when used by individuals with T2D
Study context
- Population
- Individuals with T2D currently using the Loop system; mean age 61 ± 13 years, mean BMI 31 ± 5 kg/m²; all but one on noninsulin glucose-lowering medications13 responded
- Participants
- 7 individuals
- Exposure
- Before starting Loop vs on Loop
- Outcome
- Self-reported HbA1c
Methodological detailsbefore-after comparison, self-reported data, recruited via social media
- Before-after comparison
- Self-reported data
- Recruited via social media
Main finding
As reported in the abstract
Observational data: associations, not effects.
Further findings
TIR 70-180 mg/dL
Safety
Mean
| Outcome | Before Loop | On Loop |
|---|---|---|
| Time <54 mg/dL (hypoglycaemia) | 0.04% (SD 0.06%) | 0.09% (SD 0.07%) |
Time <54 mg/dL (hypoglycaemia)
- Time in hypoglycaemia extremely low before and with Loop
Severe hypoglycaemia or DKA events while using Loop
- No severe hypoglycaemia or DKA events reported while using Loop
Original publication
Use of the Community-Derived Open-Source Automated Insulin Delivery Loop System in Type 2 Diabetes. Diabetes Technol Ther. Published 8 April 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →